Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boyer

Showing results (31-40 of 628) with videos related to

Pageof 63
Sort By:
Oncology Research|January 1, 1997
Bioreductive agents: a clinical updateM J Boyer
New Yorker (New York, N.Y. : 1925)|June 24, 2011
Changing lanes: can Danica Patrick bridge the chasm between IndyCar and NASCAR?Peter J Boyer
New Yorker (New York, N.Y. : 1925)|June 24, 2011
The covenant: Francis Collins, a fervent Christian, thought he had resolved the stem-cell debate. A federal judge disagreedPeter J Boyer
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|September 1, 1990
Are tenodesis splints cost efficient?J J Boyer
Toxicology|May 15, 1989
Toxicity of dibutyltin, tributyltin and other organotin compounds to humans and to experimental animalsI J Boyer
Chest|January 23, 1998
New chemotherapeutic agents in the treatment of non-small cell lung cancer: the Australian experienceM J Boyer
NLN Publications|February 1, 1995
Leadership and collaboration: sharing of powerM J Boyer
The Veterinary Record|July 12, 1997
Outbreak of clinical mastitis in dairy cows following 'blitz' therapyP J Boyer
The Nursing Clinics of North America|September 1, 1982
Sexuality and agingG Boyer, J Boyer
Revue Des Maladies Respiratoires|January 1, 1992
[Interstitial fibrosing pneumopathy and dermatomyositis. Pulmonary histology and prognosis]G Chatté, J Boyer
Pageof 63

Showing results (31-40 of 628) with videos related to

Sort By:
Pageof 63
Oncology Research|January 1, 1997
Bioreductive agents: a clinical updateM J Boyer
New Yorker (New York, N.Y. : 1925)|June 24, 2011
Changing lanes: can Danica Patrick bridge the chasm between IndyCar and NASCAR?Peter J Boyer
New Yorker (New York, N.Y. : 1925)|June 24, 2011
The covenant: Francis Collins, a fervent Christian, thought he had resolved the stem-cell debate. A federal judge disagreedPeter J Boyer
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|September 1, 1990
Are tenodesis splints cost efficient?J J Boyer
Toxicology|May 15, 1989
Toxicity of dibutyltin, tributyltin and other organotin compounds to humans and to experimental animalsI J Boyer
Chest|January 23, 1998
New chemotherapeutic agents in the treatment of non-small cell lung cancer: the Australian experienceM J Boyer
NLN Publications|February 1, 1995
Leadership and collaboration: sharing of powerM J Boyer
The Veterinary Record|July 12, 1997
Outbreak of clinical mastitis in dairy cows following 'blitz' therapyP J Boyer
The Nursing Clinics of North America|September 1, 1982
Sexuality and agingG Boyer, J Boyer
Revue Des Maladies Respiratoires|January 1, 1992
[Interstitial fibrosing pneumopathy and dermatomyositis. Pulmonary histology and prognosis]G Chatté, J Boyer
Pageof 63